Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].

Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, Trebst C, Warnke C, Linker R, Kerschensteiner M, Zettl U, Tumani H, Brück W, Meuth SG, Kümpfel T, Hemmer B, Wiendl H, Gold R, Zipp F.

Nervenarzt. 2019 Jul 11. doi: 10.1007/s00115-019-0760-0. [Epub ahead of print] Review. German.

PMID:
31297574
2.

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium.

Cell. 2019 Jun 27;178(1):262. doi: 10.1016/j.cell.2019.06.016. No abstract available.

3.

Towards patients' understanding of health-related quality of life-a mixed-method study in psoriasis and multiple sclerosis.

Andrees V, Westenhöfer J, Blome C, Heesen C, Augustin M, Topp J.

Qual Life Res. 2019 Jun 18. doi: 10.1007/s11136-019-02227-4. [Epub ahead of print]

PMID:
31214932
4.

Reasons for delayed admission after stroke: results of a qualitative and quantitative survey.

Alegiani AC, Albrecht S, Rahn AC, Köpke S, Thomalla G, Heesen C.

Patient Prefer Adherence. 2019 May 8;13:739-747. doi: 10.2147/PPA.S193376. eCollection 2019.

5.

Spectrally fat-suppressed coronal 2D TSE sequences may be more sensitive than 2D STIR for the detection of hyperintense optic nerve lesions.

Faizy TD, Broocks G, Frischmuth I, Westermann C, Flottmann F, Schönfeld MH, Nawabi J, Leischner H, Kutzner D, Stellmann JP, Heesen C, Fiehler J, Gellißen S, Hanning U.

Eur Radiol. 2019 May 14. doi: 10.1007/s00330-019-06255-z. [Epub ahead of print]

PMID:
31089849
6.

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Tumani H, Gold R, Hemmer B; German Competence Network of Multiple Sclerosis.

JAMA Neurol. 2019 Jul 1;76(7):841-849. doi: 10.1001/jamaneurol.2019.0905.

PMID:
31034002
7.

In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients.

Pust GEA, Pöttgen J, Randerath J, Lau S, Heesen C, Gold SM, Penner IK.

J Neurol. 2019 Jul;266(7):1663-1673. doi: 10.1007/s00415-019-09311-2. Epub 2019 Apr 19.

PMID:
31004211
8.

Long-term physical activity in people with multiple sclerosis: exploring expert views on facilitators and barriers.

Riemann-Lorenz K, Wienert J, Streber R, Motl RW, Coote S, Heesen C.

Disabil Rehabil. 2019 Mar 23:1-13. doi: 10.1080/09638288.2019.1584253. [Epub ahead of print]

PMID:
30907162
9.

Impairment and restrictions in possibly benign multiple sclerosis.

Schaefer LM, Poettgen J, Fischer A, Gold S, Stellmann JP, Heesen C.

Brain Behav. 2019 Apr;9(4):e01259. doi: 10.1002/brb3.1259. Epub 2019 Mar 18.

10.

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis.

Faizy TD, Broocks G, Thaler C, Rauch G, Gebert P, Stürner KH, Flottmann F, Leischner H, Kniep HC, Stellmann JP, Heesen C, Fiehler J, Gellißen S, Hanning U.

Front Neurol. 2019 Feb 22;10:133. doi: 10.3389/fneur.2019.00133. eCollection 2019.

11.

Emotions towards magnetic resonance imaging in people with multiple sclerosis.

Engels K, Schiffmann I, Weierstall R, Rahn AC, Daubmann A, Pust G, Chard D, Lukas C, Scheiderbauer J, Stellmann JP, Heesen C.

Acta Neurol Scand. 2019 Jun;139(6):497-504. doi: 10.1111/ane.13082. Epub 2019 Mar 28.

PMID:
30802931
12.

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.

Stork L, Brück W, von Gottberg P, Pulkowski U, Kirsten F, Glatzel M, Rauer S, Scheibe F, Radbruch H, Hammer E, Stürner KH, Kaulen B, Heesen C, Hoffmann F, Brock S, Pawlitzki M, Bopp T, Metz I.

Mult Scler. 2019 Jan 18:1352458518819098. doi: 10.1177/1352458518819098. [Epub ahead of print]

PMID:
30657420
13.

Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.

Beckmann H, Augustin M, Heesen C, Poettgen J, Blome C.

Mult Scler Relat Disord. 2019 Feb;28:256-261. doi: 10.1016/j.msard.2018.12.021. Epub 2018 Dec 17.

PMID:
30639826
14.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

15.

Guest Editorial: Shared Decision Making in Managing Multiple Sclerosis: Revisiting the Research Agenda.

Heesen C, Rahn AC.

Int J MS Care. 2018 Nov-Dec;20(6):v-vi. doi: 10.7224/1537-2073.2018-098. No abstract available.

16.

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh FT, Kümpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl UK, Zipp F, Hemmer B, Meuth SG, Gold R, Wiendl H, Salmen A; German Competence Network Multiple Sclerosis (KKNMS).

J Neurol. 2019 Feb;266(2):386-397. doi: 10.1007/s00415-018-9142-y. Epub 2018 Dec 4.

17.

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.

Giordano A, Liethmann K, Köpke S, Poettgen J, Rahn AC, Drulovic J, Beckmann Y, Sastre-Garriga J, Galea I, Heerings M, Jongen PJ, Vettorazzi E, Solari A, Heesen C; AutoMS group.

PLoS One. 2018 Nov 29;13(11):e0208004. doi: 10.1371/journal.pone.0208004. eCollection 2018.

18.

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium.

Cell. 2018 Nov 29;175(6):1679-1687.e7. doi: 10.1016/j.cell.2018.09.049. Epub 2018 Oct 18.

19.

Prognostic information for people with MS: Impossible or inevitable?

Heesen C, Scalfari A, Galea I.

Mult Scler. 2018 Oct 16:1352458518807101. doi: 10.1177/1352458518807101. [Epub ahead of print]

PMID:
30325713
20.

Information provision for people with multiple sclerosis.

Köpke S, Solari A, Rahn A, Khan F, Heesen C, Giordano A.

Cochrane Database Syst Rev. 2018 Oct 14;10:CD008757. doi: 10.1002/14651858.CD008757.pub3.

PMID:
30317542

Supplemental Content

Loading ...
Support Center